These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21802122)
1. Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness. Lin HY; Park HY; Radlein S; Mahajan NP; Sellers TA; Zachariah B; Pow-Sang J; Coppola D; Ganapathy V; Park JY Urology; 2011 Oct; 78(4):971.e1-9. PubMed ID: 21802122 [TBL] [Abstract][Full Text] [Related]
2. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor. Park JY; Zheng W; Kim D; Cheng JQ; Kumar N; Ahmad N; Pow-Sang J Cancer Detect Prev; 2007; 31(5):359-65. PubMed ID: 18037591 [TBL] [Abstract][Full Text] [Related]
3. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Park JY; Helm JF; Zheng W; Ly QP; Hodul PJ; Centeno BA; Malafa MP Pancreas; 2008 May; 36(4):e32-9. PubMed ID: 18437076 [TBL] [Abstract][Full Text] [Related]
4. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Park JY; Kim D; Yang M; Park HY; Lee SH; Rincon M; Kreahling J; Plass C; Smiraglia DJ; Tockman MS; Kim SJ Lung Cancer; 2013 Mar; 79(3):198-204. PubMed ID: 23273563 [TBL] [Abstract][Full Text] [Related]
5. Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8. Hong C; Maunakea A; Jun P; Bollen AW; Hodgson JG; Goldenberg DD; Weiss WA; Costello JF Cancer Res; 2005 May; 65(9):3617-23. PubMed ID: 15867356 [TBL] [Abstract][Full Text] [Related]
6. SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas. Brim H; Kumar K; Nazarian J; Hathout Y; Jafarian A; Lee E; Green W; Smoot D; Park J; Nouraie M; Ashktorab H PLoS One; 2011; 6(6):e20216. PubMed ID: 21687703 [TBL] [Abstract][Full Text] [Related]
7. Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas. Porra V; Ferraro-Peyret C; Durand C; Selmi-Ruby S; Giroud H; Berger-Dutrieux N; Decaussin M; Peix JL; Bournaud C; Orgiazzi J; Borson-Chazot F; Dante R; Rousset B J Clin Endocrinol Metab; 2005 May; 90(5):3028-35. PubMed ID: 15687339 [TBL] [Abstract][Full Text] [Related]
8. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma]. Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354 [TBL] [Abstract][Full Text] [Related]
9. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells. Zhang Y; Bao YL; Yang MT; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX Int J Biochem Cell Biol; 2010 Dec; 42(12):1964-72. PubMed ID: 20732443 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of SLC5A8 inactivation in breast cancer. Elangovan S; Pathania R; Ramachandran S; Ananth S; Padia RN; Srinivas SR; Babu E; Hawthorn L; Schoenlein PV; Boettger T; Smith SB; Prasad PD; Ganapathy V; Thangaraju M Mol Cell Biol; 2013 Oct; 33(19):3920-35. PubMed ID: 23918800 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population. Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589 [TBL] [Abstract][Full Text] [Related]
12. CD24 is a genetic modifier for risk and progression of prostate cancer. Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469 [TBL] [Abstract][Full Text] [Related]
13. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Helm J; Coppola D; Ganapathy V; Lloyd M; Centeno BA; Chen DT; Malafa MP; Park JY Pancreas; 2012 Aug; 41(6):904-9. PubMed ID: 22450368 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the human SLC5A8 gene promoter. Zhang Y; Bao YL; Wu Y; Yu CL; Sun Y; Li YX Cancer Genet Cytogenet; 2010 Jan; 196(2):124-32. PubMed ID: 20082847 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer. Ueno M; Toyota M; Akino K; Suzuki H; Kusano M; Satoh A; Mita H; Sasaki Y; Nojima M; Yanagihara K; Hinoda Y; Tokino T; Imai K Tumour Biol; 2004; 25(3):134-40. PubMed ID: 15361710 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma. Ikeda K; Shiraishi K; Koga T; Motooka Y; Fujino K; Shibata H; Mori T; Suzuki M Ann Thorac Surg; 2015 May; 99(5):1755-9. PubMed ID: 25827678 [TBL] [Abstract][Full Text] [Related]
17. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858 [TBL] [Abstract][Full Text] [Related]
18. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Li H; Myeroff L; Smiraglia D; Romero MF; Pretlow TP; Kasturi L; Lutterbaugh J; Rerko RM; Casey G; Issa JP; Willis J; Willson JK; Plass C; Markowitz SD Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8412-7. PubMed ID: 12829793 [TBL] [Abstract][Full Text] [Related]
19. Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer. Zhu Q; Meng Y; Li S; Xin J; Du M; Wang M; Cheng G Gene; 2022 Jan; 808():145953. PubMed ID: 34500048 [TBL] [Abstract][Full Text] [Related]
20. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. Thangaraju M; Cresci G; Itagaki S; Mellinger J; Browning DD; Berger FG; Prasad PD; Ganapathy V J Gastrointest Surg; 2008 Oct; 12(10):1773-81; discussion 1781-2. PubMed ID: 18661192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]